Neuronally expressed PDL1, not PD1, suppresses acute nociception

Area of Science:

• Neuroimmunology
• Pain research
• Molecular biology

Background:

• Programmed death-ligand 1 (PDL1) typically mediates immunosuppression by binding to PD1 on immune cells.
• Previous research indicates PD1 is mainly on immune cells, not neurons.
• Neuronal PDL1 expression and its signaling pathways (reverse signaling) are largely uncharacterized.

Purpose of the Study:

• To investigate the expression and function of neuronal PDL1.
• To explore the role of neuronal PDL1 in pain modulation.
• To elucidate the intracellular signaling mechanisms of PDL1 reverse signaling in neurons.

Main Methods:

• Single neuron qPCR, immunolabeling, and flow cytometry to assess PD1 and PDL1 expression in neurons.
• Administration of soluble PD1 to mice to study its effects on nociception.
• Calcium imaging in dissociated sensory neurons to examine TRPV1 activity.
• Behavioral tests in wild-type and PDL1 knockout mice to assess pain responses.

Main Results:

• Widespread PDL1 expression was found in sensory and sympathetic neurons, while PD1 was absent.
• Administration of soluble PD1 reduced pain behaviors induced by capsaicin.
• Exogenous PD1 decreased TRPV1-dependent calcium transients and TRPV1 membrane expression in sensory neurons.
• PD1 administration had no effect on pain in sensory neuron-specific PDL1 knockout mice.

Conclusions:

• Neuronal PDL1 is expressed and functional, playing a role in modulating pain sensitivity.
• Activation of neuronal PDL1 by soluble PD1 can reduce nociception via TRPV1.
• Neuronal PDL1 represents a potential homeostatic mechanism for regulating acute pain.